Trident Lifeline Stock Screener | Share Price & Fundamental Analysis
TLL
Pharmaceuticals
Screen Trident Lifeline share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹320.75 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
4.07
EPS (TTM)
₹10.22
Dividend Yield
-
Debt to Equity
0.62
52W High
-
52W Low
-
Operating Margin
23.00%
Profit Margin
16.13%
Revenue (TTM)
₹31.00
EBITDA
₹9.00
Net Income
₹5.00
Total Assets
₹156.00
Total Equity
₹70.00
Trident Lifeline Share Price History - Stock Screener Chart
Screen TLL historical share price movements with interactive charts. Analyze price trends and patterns.
Trident Lifeline Company Profile - Fundamental Screener
Screen Trident Lifeline company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TLL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0MKA01014
Trident Lifeline Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen TLL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 156 | 87 | 63 | 14 |
| Current Assets | 90 | 52 | 49 | 11 |
| Fixed Assets | 44 | 21 | 3 | 1 |
| Liabilities | ||||
| Total Liabilities | 156 | 87 | 63 | 14 |
| Current Liabilities | 33 | 13 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 70 | 54 | 47 | 5 |
| Share Capital | 12 | 12 | 12 | 8 |
| Reserves & Surplus | 53 | 40 | 34 | -3 |
Screen TLL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31 | 25 | 36 | 12 | 16 | 14 | 21 | 7 | 10 | 9 | 9 | 10 | 8 | 6 | 9 |
| Expenses | 23 | 18 | 26 | 8 | 11 | 11 | 17 | 6 | 8 | 7 | 7 | 7 | 6 | 5 | 7 |
| EBITDA | 9 | 7 | 10 | 5 | 5 | 4 | 4 | 2 | 3 | 2 | 3 | 2 | 2 | 1 | 2 |
| Operating Profit % | 23.00% | 22.00% | 25.00% | 34.00% | 26.00% | 19.00% | 12.00% | 20.00% | 22.00% | 20.00% | 23.00% | 21.00% | 18.00% | 14.00% | 20.00% |
| Depreciation | 1 | 2 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 7 | 4 | 6 | 4 | 4 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Tax | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | -1 |
| Net Profit | 5 | 3 | 6 | 3 | 3 | 2 | 2 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 3 |
| EPS | 4.27 | 2.66 | 6.15 | 2.42 | 2.69 | 1.99 | 1.41 | 0.94 | 1.48 | 1.22 | 1.72 | 1.77 | 1.15 | 0.88 | 15.02 |
Trident Lifeline Cash Flow Screener - Liquidity Fundamentals
Screen TLL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -10 | 2 | -19 | 0 |
| Investing Activities | -14 | -20 | -10 | 0 |
| Financing Activities | 20 | 11 | 42 | 1 |
| Net Cash Flow | -4 | -7 | 14 | 0 |
Screen TLL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 63.04% | 63.04% | 63.11% | 63.26% | 67.48% | 65.51% | 62.99% | 62.99% |
| FII Holding | 6.62% | 7.21% | 7.71% | 7.56% | 6.02% | 6.02% | 6.09% | 6.09% |
| DII Holding | 0.09% | 0.39% | 0.41% | 0.38% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.26% | 17.90% | 17.63% | 17.34% | 16.39% | 18.37% | 19.40% | 18.90% |
| Other Holding | 11.99% | 11.45% | 11.14% | 11.46% | 10.10% | 10.10% | 11.52% | 12.02% |
| Shareholder Count | 534 | 549 | 554 | 549 | 500 | 502 | 507 | 523 |
Trident Lifeline Dividend Screener - Share Yield Analysis
Screen TLL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Trident Lifeline Index Membership - Market Screener Classification
Screen TLL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Trident Lifeline Market Events Screener - Corporate Actions
Screen TLL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -0.35% | ||
| Annual General Meeting | NA | 18.05% | ||
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 1.43% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 1.19% |
| 2025-05-09 | 2025-05-09 | Extraordinary General Meeting | NA | 13.60% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 5.19% |
| 2025-01-22 | 2025-01-22 | Quarterly Result Announcement | NA | 5.83% |
| 2024-10-19 | 2024-10-19 | Quarterly Result Announcement | NA | 4.93% |
Trident Lifeline Competitors Screener - Peer Comparison
Screen TLL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Trident Lifeline Company Announcements - News Screener
Screen TLL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-02 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-30 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On December 16 2025 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-12-30 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-12-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-12-05 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On December 05 2025 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-11-21 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On November 21 2025 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Allotment Of Securities | View |
| 2025-11-14 | Revised Unaudited Financial Results For The Half Year Ended September 30 2025. | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-11 | Result-Financial Result For The Half Year Ended 30.09.2025 | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of Board Meeting Held On 11.11.2025 | View |
| 2025-11-04 | Board Meeting Intimation for Declaration Of Un-Audited Result For Half Year Ended 30.09.2025 | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |